Patents/Assignees

IMMUNE SYSTEM KEY Ltd.

1 patent in portfolio

US11813305utility2023
Endoplasmic Reticulum Stress as a Predictive Tool in Cancer Therapy and a Combination Therapy for the Treatment of Cancer
0 cites